Opendata, web and dolomites
H2020 projects about "dopaminergic"
The page lists 37 projects related to the topic "dopaminergic".
| # | |||
|---|---|---|---|
| 1 | FAIR-PARK-II | Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone | 2015 |
| 2 | PROPAG-AGEING | The continuum between healthy ageing and idiopathic Parkinson Disease within a propagation perspective of inflammation and damage: the search for new diagnostic, prognostic and therapeutic targets | 2015 |
| 3 | REMOTIVATE | Reward revisited: Towards a comprehensive understanding of motivational influences on human cognition | 2015 |
| 4 | CoordinatedDopamine | Coordination of regional dopamine release in the striatum during habit formation and compulsive behaviour | 2015 |
| 5 | PROPHETIC | PROPHETIC:An innovating Personal Healthcare Service for a holistic remote management and treatment of Parkinson patients. | 2015 |
| 6 | MediVAC | Bio-sustainable production of natural medicines from Vitex | 2015 |
| 7 | MELANOPARK | Investigating the LRRK2-melanin connection through phosphoproteomics of isogenic melanoma cells | 2015 |
| 8 | FISHDOPA | Dopaminergic neurons and the reward system in fish: a functional neuroanatomical multidisciplinary study | 2016 |
| 9 | ROSNPD | Selective vulnerability of neuronal degeneration in Parkinson’s disease: the load of routine behaviour | 2016 |
| 10 | NeuroInCellNMR | In-cell NMR monitoring of alpha-Synuclein aggregation in neuronal cells | 2015 |
| 11 | PROGSY | Prosaposin and GPR37 in synucleinopathies | 2015 |
| 12 | MotMotLearn | Motivating Motor Learning: The Role of Reward, Punishment and Dopamine | 2015 |
| 13 | MAGNEURON | Hijacking cell signalling pathways with magnetic nanoactuators for remote-controlled stemcell therapies of neurodegenerative disorders | 2016 |
| 14 | CoCA | Comorbid Conditions of Attention deficit / hyperactivity disorder | 2016 |
| 15 | SysMedPD | Systems Medicine of Mitochondrial Parkinson’s Disease | 2015 |
| 16 | INTEGRATE | Central integration of metabolic and hedonic cues in metabolic health | 2016 |
| 17 | STRESNET | Stress Resilience and Network-Feedback Training | 2016 |
| 18 | CholAminCo | Synergy and antagonism of cholinergic and dopaminergic systems in associative learning | 2017 |
| 19 | FUNCOPLAN | Functions of plasticity in adult-born neurons | 2017 |
| 20 | PD UpReg | Gene knock-up via 3’UTR targeting to treat Parkinson’s disease | 2017 |
| 21 | Brain2Bee | How dopamine affects social and motor ability - from the human brain to the honey bee | 2018 |
| 22 | ParallelMemories | Cooperative and competitive parallel memory units for choice behaviors | 2018 |
| 23 | DOPANF | Dopaminergic midbrain modulations by (adaptive) neurofeedback | 2018 |
| 24 | DYCOCIRC | Basal ganglia circuit mechanisms underlying dynamic cognitive behavior | 2018 |
| 25 | SCCMMI | Single cell correlates of memory, motivation and individuality | 2018 |
| 26 | gaitDCODE | Decoding impairments of gait and balance from local field potentials in patients with Parkinson's disease. | 2018 |
| 27 | TOLKEDA | Modulating brain structural plasticity versus neurodegeneration via a novel mechanism involving neurotrophins and dopamine, Tolls and Kek truncated-Trk-like receptors in Drosophila. | 2018 |
| 28 | CORLID | Cortical markers of L-DOPA-induced dyskinesias | 2019 |
| 29 | INTEGRATE | An integrated hypothesis for cognitive and positive symptoms in schizophrenia | 2018 |
| 30 | LeaRNN | Principles of Learning in a Recurrent Neural Network | 2019 |
| 31 | PARNANT | Pathogenetic pathways in age-related neurodegenerations as novel therapeutic targets for Parkinson’s disease | 2019 |
| 32 | RememberEx | Human Subcortical-Cortical Circuit Dynamics for Remembering the Exceptional | 2019 |
| 33 | VINCI | The Value of Information and Choice to Improve Control. | 2020 |
| 34 | AND-PD | COMORBIDITY MECHANISMS OF ANXIETY AND PARKINSON’S DISEASE | 2020 |
| 35 | ParkIFNAR | Soluble IFNAR2 in Parkinson's disease and its role in the regulation of IFNβ in a neuroinflammatory context. | 2020 |
| 36 | BMPARK | Development of BMP2 Neurotrophic Therapy for Parkinson’s Disease | 2020 |
| 37 | HT4PD | The role of the serotonin 5-HT4 receptor in motor and non-motor symptoms of Parkinson’s disease | 2021 |